Picture of IRIDEX logo

IRIX — IRIDEX News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Iridex Corp Reports Results For The Quarter Ended In December: Earnings Summary

* IRIDEX Corp  IRIX.OQ  reported a quarterly adjusted loss
of 7
cents​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of 11
cents per share.
    * Revenue fell 0.4% to $15.20 million from a year ago;
analysts
expected $15.16 million. 
    * IRIDEX Corp's reported EPS for the quarter was a loss of 7
cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * IRIDEX Corp shares had risen by 13.4% this quarter.
    * The company reported a quarterly loss of $1.15 million.
    * Wall Street's median 12-month price target for IRIDEX Corp
is
$4.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 10:41 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.11          -0.07          Beat
 Sep. 30 2022      -0.14          -0.11          Beat
 Jun. 30 2022      -0.15          -0.14          Beat
 Mar. 31 2022      -0.16          -0.15          Beat

Recent news on IRIDEX

See all news